ADT1536-Ravagalimab Biosimilar-(CD40/TNFRSF5)-Research Biosimilar Antibody
- +1 609-736-0910
- info@alphalifetech.com
- 90 State Street, STE 700 Office 40, Albany, NY 12207 United States
Product Background
Catalog Number |
ADT1536 |
Product Name |
ADT1536-Ravagalimab Biosimilar-(CD40/TNFRSF5)-Research Biosimilar Antibody |
Alternate Names |
anti cd40, anti-mouse cd40, anti-cd40 antibody, anti cd40 antibody, cd40 antibody, anti-mouse cd40 antibody, recombinant cd40, cd40 antibody, anti-cd40 monoclonal antibody, cd40 antibodies, cd40 recombinant antibody, cd40 blocking antibody |
Alias |
ABBV-323 |
Clonity |
Monoclonal |
Host |
CHO Cells |
Species |
Human |
Target |
CD40/TNFRSF5 |
Gene ID |
958 |
Isotype |
IgG1 Kappa |
Size |
1mg, 5mg |
Research Area |
Immunology |
CAS Number |
2050816-56-1 |
Product Description |
Ravagalimab is under investigation in clinical trial NCT03695185 (A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe It Is in Participants With Moderate to Severe Ulcerative Colitis Who Failed Prior Therapy). |
Application |
ELISA, WB |
Purity |
>95% as determined by SDS-PAGE |
Concentration |
batch dependent |
Buffer |
Supplied in PBS, PH7.5 |
Storage |
Store at -20 °C for 12 months. Store at -80 °C for long term storage. |
Shipping Condition |
Shipped on ice packs. |
Note |
This product is for research use only. |
|
Reference 1. Vos S, et al. Invest Ophthalmol Vis Sci, 2023 Jun 1. PMID 37294707
2. Sghiri R, et al. Clin Rheumatol, 2022 Jun. PMID 35107652
3. Jiang H, et al. Front Endocrinol (Lausanne), 2021. PMID 34867801
|